Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
94.38
0.00 (0.00%)
Oct 9, 2025, 11:52 AM EDT - Market open
Merus Employees
As of December 31, 2024, Merus had 321 total employees, including 260 full-time and 61 part-time employees. The number of employees increased by 92 or 40.17% compared to the previous year.
Employees
321
Change (1Y)
92
Growth (1Y)
40.17%
Revenue / Employee
$175,165
Profits / Employee
-$1,200,997
Market Cap
7.15B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 321 | 92 | 40.17% |
Dec 31, 2023 | 229 | 8 | 3.62% |
Dec 31, 2022 | 221 | 80 | 56.74% |
Dec 31, 2020 | 141 | 9 | 6.82% |
Dec 31, 2019 | 132 | 34 | 34.69% |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
MRUS News
- 8 days ago - MERUS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Merus N.V. - MRUS - Business Wire
- 10 days ago - Genmab Makes $8 Billion Bet On Merus With Potential Cancer Breakthrough - Benzinga
- 10 days ago - This Dutch Drugmaker's Stock Is Jumping 38%. Here's Why It's Being Acquired. - Barrons
- 10 days ago - Months after cancer drug trial, Merus agrees to be bought at 41% premium - Market Watch
- 10 days ago - Genmab to acquire Dutch biotech Merus in $8B deal to expand cancer pipeline - Invezz
- 10 days ago - Genmab to buy Dutch cancer drugmaker Merus for $8 billion - Reuters
- 10 days ago - Genmab to Acquire Merus, Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model - Business Wire
- 6 weeks ago - Merus to Present at the 2025 Wells Fargo Healthcare Conference - GlobeNewsWire